Literature DB >> 24137278

Evaluation of conservative treatment and timing of surgical intervention for mild forms of cervical spondylotic myelopathy.

Ling-DE Kong1, Ling-Chen Meng, Lin-Feng Wang, Yong Shen, Pan Wang, Zi-Kun Shang.   

Abstract

The optimal management approach for patients with mild forms of cervical spondylotic myelopathy (MCSM) has not been well established. The aim of the present study was to investigate the outcome of conservative treatment, identify prognostic factors and provide evidence for the timing of surgical intervention. A total of 90 patients with MCSM attending hospital between February 2007 and January 2009 were prospectively enrolled. Initially, all patients received conservative treatment and were followed up periodically. When a deterioration in myelopathy was clearly identified, surgical treatment was conducted. Clinical and radiological factors correlating with the deterioration were examined, and final clinical outcomes were evaluated using the Japanese Orthopedic Association (JOA) score. At the end of January 2012, follow-ups of >3 years were completed. Seventy-eight patients were available for data analysis. Only 21 patients (26.9%) deteriorated and underwent surgery thereafter (group A), while the remaining 57 patients (73.1%) were treated conservatively throughout (group B). Statistical analysis revealed that segmental instability and cervical spinal stenosis were adverse factors for the prognosis of conservative treatment. Although the JOA scores of the patients in group A declined initially, following surgical intervention, no significant differences were identified in JOA scores between the two groups at the time of the final follow-up (P=0.46). In summary, conservative treatment is effective in MCSM patients. Patients with segmental instability and cervical spinal stenosis have a tendency to deteriorate, but conservative treatment remains the recommendation for the first action. If the myelopathy deteriorates during conservative treatment, timely surgical intervention is effective.

Entities:  

Keywords:  cervical myelopathy; conservative treatment; prognosis; surgical treatment

Year:  2013        PMID: 24137278      PMCID: PMC3786935          DOI: 10.3892/etm.2013.1224

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Cervical spondylotic myelopathy (CSM) is a degenerative disease of the cervical spine in which the severity of clinical signs and symptoms depends on the pathophysiology of the spinal cord. Since osteoarthritic degeneration of the cervical spine may provoke irreversible damage to the spinal cord and delays in surgical treatment tend to result in a poor outcome (1–3), early decompression surgery is usually recommended for patients with a definite diagnosis of moderate or severe CSM (4–6). However, in patients with mild, non-progressive or slowly progressive CSM, a relatively benign natural course has been observed (7,8) and the superiority of surgical treatment over conservative treatment has not been established (9–11). It appears that conservative treatment is the preferred choice for these patients since it avoids the complications of surgery and is less expensive (12,13). However, even with the same treatment protocols, the outcome of conservative treatment for mild forms of CSM (MCSM) varies between individuals. Although efforts have been made to determine prognostic factors for the deterioration of MCSM, results remain highly controversial (7,8,14–16). Furthermore, for MCSM patients with adverse prognostic factors, little is known with regard to the optimal timing of surgery. Surgeons are faced with a dilemma as to whether surgery should be performed as early as possible or only after conservative treatment has failed. With the aim of providing evidence-based guidelines for the effective treatment of MCSM, the present prospective study was conducted to investigate the clinical outcome of conservative treatment, identify factors associated with the prognosis of conservative treatment and to verify whether it is too late to perform surgical procedures after conservative treatment fails.

Materials and methods

Inclusion and exclusion criteria

Following approval from the ethics committee of The Third Hospital of Hebei Medical University (Shijiazhuang, China), 90 MCSM patients attending The Third Hospital of Hebei Medical University (Shijiazhuang, China) between February 2007 and January 2009 were prospectively enrolled in this study, and informed consent was obtained from all patients. Inclusion criteria for patients were as follows: objective clinical findings of CSM, for example, increased deep tendon reflexes, positive pathological reflexes and abnormal sensory disturbances; correlative spinal cord compression on magnetic resonance imaging (MRI); a Japanese Orthopedic Association (JOA) score (Table I) of ≥13; a recent non-progressive process; and consent provided for the recommended treatment plan. Patients with ossification of the posterior longitudinal ligament, traumatic cervical myelopathy, motor neurone disease, multiple sclerosis, progressive polyarthritis, congenital anomalies and vitamin B12 deficiency were excluded from the study.
Table I

Japanese Orthopaedic Association (JOA) scores for assessment of cervical myelopathy.

CategoryScore (points)
Motor function of the upper extremity
 Unable to eat with either chopsticks or a spoon0
 Able to eat with a spoon, but not with chopsticks1
 Able to eat with chopsticks, but inadequately2
 Able to eat with chopsticks, but awkwardly3
 Normal4
Motor function of the lower extremity
 Unable to walk0
 Needs a cane or other walking aid on flat ground1
 Needs walking aid only on stairs2
 Able to walk unaided, but slowly3
 Normal4
Sensory function
 Upper extremity
  Apparent sensory disturbance0
  Minimal sensory disturbance1
  Normal2
 Lower extremity
  Apparent sensory disturbance0
  Minimal sensory disturbance1
  Normal2
 Trunk
  Apparent sensory disturbance0
  Minimal sensory disturbance1
  Normal2
Bladder function
 Urinary retention or incontinence0
 Severe dysuria (sense of retention)1
 Slight dysuria (pollakiuria, retardation)2
 Normal3

The score in a normal subject is the total of the highest scores: (I + II + III + IV) = 17 points.

Treatment protocol

Each patient was hospitalized and received treatment according to the following protocol. The initial treatment comprised continuous cervical traction [Good-Samaritan traction (17)] in which the neck of the patient was placed in a position of slight flexion for 8 h per day for ~2 weeks. Regardless of the outcome of cervical traction, patients were discharged. Hyper-extended or hyper-flexed neck positions, slips and falls, intense exercise and other potentially dangerous activities in daily life were avoided at home. Patients were followed up periodically every three months and advised to visit the hospital immediately if their symptoms became exacerbated. Surgery was performed on patients who experienced a deterioration of myelopathy that resulted in JOA scores of <13 with a reduction of ≥2 points.

Surgical protocol

The procedures included anterior and posterior approaches, the choice of which depended on the cervical alignment and the levels and sources of compression. Anterior discectomy followed by autologous bone grafting and cervical plate fixation were adopted for patients with 1- or 2-level compression, particular those with greater compression on the anterior side. In patients exhibiting preserved cervical lordosis and >3-level canal stenosis, C3 to C6 (or C7) laminoplasty was performed. In the case of significant compression on the posterior side, laminoplasty was also selected, even if the patients exhibited <3-level compression. All surgeries were performed within one month of deterioration of myelopathy. At the end of the study, all surgically treated patients were followed up for ≥1 year postoperatively.

Outcome assessments

In order to analyze the prognostic factors, relevant clinical factors, including gender, age and duration of disease, were collected from the records of the patients. On the first visit to the hospital, all patients underwent plain antero-posterior, lateral and extension-flexion radiographs with a tube-to-film distance of 120 cm. All patients underwent high-resolution MRI with a 1.5-T imager (Siemens Magnetom Symphony; Siemens, Berlin, Germany). The conditions for the MRI study were as previously described (3). Plain radiographs and MRI yielded imaging parameters as follows: The C2–C7 angle was measured using the Cobb method, which was determined by the inferior margin of C2 body and the inferior margin of C7 body on lateral radiographs; segmental instability was considered to be present if >2 mm of slippage displacement was observed on extension-flexion radiographs at the compression-affected levels (18). The sagittal diameters of the cerebrospinal fluid (CSF) column were measured at the mid-vertebra level on T2 sagittal MRI from C4 to C7, and the mean value was calculated (Fig. 1). The extent of spinal cord compression was defined by the ratio of the spinal cord diameter of the narrowest part to that of the C2/3 intervertebral level using sagittal images on T2-weighted MRI (Fig. 1). The number of compression-affected levels on T2-weighted MRI was also recorded. Data measurements were performed twice by a single observer and the mean value was used for analysis.
Figure 1

Measurement of diameters of the cerebrospinal fluid (CSF) column and spinal cord compression on T2 sagittal MRI. L1–L4 were diameters of the CSF at the mid-vertebra level from C4 to C7. Diameter of the CSF column (mm) = (L1+L2+L3+L4)/4. a and b are the spinal cord diameters of narrowest part and the C2/3 intervertebral level. Spinal cord compression (%) = a/b.

To investigate treatment outcomes, JOA scores at the time of the initial visit and final follow-up were analyzed. For patients who neurologically deteriorated and therefore underwent surgery, JOA scores at the time of conversion to surgery were also evaluated. To determine which prognostic factors correlated with failed conservative treatment, each of the clinical and radiological factors was compared between patients who were treated conservatively throughout and those who had undergone surgery by the final follow-up.

Statistical analysis

A parametric analysis was performed using the Mann-Whitney U test. Categorical variables were analyzed using the Fisher's exact test. The Statistical Package for the Social Sciences (version 13.0 for Windows; SPSS, Inc., Chicago, IL, USA) was used for the statistical analysis. P<0.05 was considered to indicate a statistically significant difference.

Results

A total of 90 patients with MCSM were enrolled in this study. By the end of January 2012, nine patients had withdrawn from the study, one patient was affected by an acute spinal cord injury and two patients had succumbed to unrelated causes (Fig. 2). At the final follow-up, 78 (45 male and 33 female) of 90 patients (follow-up rate, 86.7%) were investigated. The average age at first visit was 57.8 years (range, 37–71 years). The average follow-up period was 40 months (range, 36–56 months). The mean JOA scores at the time of the first and the last follow-up were 14.1 points (range, 13–16 points) and 14.0 points (range, 10–16 points), respectively (Table II).
Figure 2

Treatment profile in of patients with mild forms of cervical spondylotic myelopathy (MCSM) in the present study.

Table II

Baseline demographic characteristics.

VariableValue
No. of patients78
No. of deteriorated patients21
Gender (male:female)45:33
Age (years)37–71 (57.8)
Follow-up period (months)36–56 (40.0)
JOA scores of initial follow-up13–16 (14.1)
JOA scores of final follow-up10–16 (14.0)

Values in parentheses are mean values. JOA, Japanese Orthopedic Association.

The 78 patients were divided into two groups according to the results of conservative treatment. The 21 patients who had gradual reductions in JOA scores to a mean of 2.9 points (range, 2–5 points) and underwent surgery were group A, while the remaining 57 patients who were treated conservatively throughout were group B. Among the 21 patients in group A, 18 patients underwent anterior decompression and fusion and three underwent laminoplasty. There were no incidences of infections, cervical fluid leakage, esophageal or tracheal ruptures and neurological deterioration. Transient recurrent laryngeal nerve palsy was observed in one patient without further management. Three patients reported axial pain, which subsided gradually in 1–2 months without any treatment. The prognostic factors correlating with the outcome of conservative treatment are displayed in Table III. The mean diameter of the CSF column in group A was significantly smaller than that in group B (10.7±1.8 vs. 12.1±1.2 mm, P=0.02). Additionally, nine of 21 (42.9%) patients exhibited segmental instability in group A compared with only eight of 57 (14.0%) patients in group B. This difference was statistically significant (P=0.01). No significant differences were identified between the two groups with regard to age, gender, duration of disease, C2–C7 angle, signal intensity changes on MRI, the number of compression-affected levels and the degree of spinal cord compression.
Table III

Risk factors of neurological deterioration.

FactorGroup A (n=21)Group B (n=57)P-value
Age (years)58.8±11.357.5±10.50.62
Gender (male:female)13:832:250.80
Duration of disease (months)23.3±19.219.3±15.00.70
C2–C7 angle (degrees)9.9±10.711.6±10.70.61
Segmental instability (yes:no)9:128:490.01
Spinal cord intensity changes (yes:no)14:726:310.13
Compression-affected levels (no.)1.41.30.53
Diameter of the CSF column (mm)10.7±1.812.1±1.20.02
Spinal cord compression (%)78.2±6.375.3±8.10.19

Measurement results are expressed as the mean ± SD. Group A, deterioration after conservative treatment; Group B, no deterioration after conservative treatment; CSF, cerebrospinal fluid.

Fig. 3 shows the mean JOA scores at different follow-up periods. On the first visit to the hospital, the mean JOA scores were 14.0±1.1 in group A and 14.2±1.0 in group B, and no significant difference was identified between the two groups (P=0.62). Although the mean JOA score of group A decreased to 11.1±0.8 as the condition deteriorated, following timely surgical intervention, the final mean JOA scores of the two groups (13.4±2.5 in group A and 14.2±1.3 in group B, P=0.46) were not observed to be significantly different.
Figure 3

Changes in Japanese Orthopedic Association (JOA) scores.

Discussion

The present study revealed a satisfactory outcome of conservative treatment in MCSM patients; only 21 of 78 (26.9%) patients experienced a deterioration of myelopathy during a >3-year follow-up. This demonstrated that in the majority of the MCSM patients, neurological function either improved or was non-progressive. This finding is consistent with a number of previous reports. Oshima et al(7) conducted a retrospective study with a mean follow-up period of 78 months to investigate the natural course of MCSM; 16 of 43 (37.2%) patients exhibited a deterioration in motor function and underwent decompression surgery. Following Kaplan-Meier survival analysis, it was revealed that 82 or 56% of patients in the study did not require surgery five or 10 years after initial treatment, respectively. Sumi et al(8) performed a prospective cohort study that only focused on MCSM and had a 5–12-year follow-up period, in which deterioration in myelopathy was observed in 14 of 55 (25.5%) patients, whereas 41 of 55 (74.5%) patients maintained mild myelopathy without deterioration through the follow-up period. The selection of patients who will truly benefit from conservative treatment is challenging to surgeons. It is therefore critical to investigate which prognostic factors aggravate MCSM. A number of predicting factors that may affect the surgical outcomes of CSM have been reported, including age (1,19), duration of disease (1), cervical curvature (20), signal intensity changes in MRI (3,21) and extent of spinal cord compression (22). Despite this, studies reporting the prognostic factors of conservative treatment for MCSM are limited, and the conclusions controversial. Shimomura et al(14) reported that circumferential spinal cord compression in the maximum compression segment in axial MRI was the only prognostic factor for MCSM. Subsequently, Sumi et al(8) further followed the same patients for >5 years and reported that the presence of angular-edged deformities of the spinal cord in T1-weighted axial MRI is another risk factor that aggravates myelopathy. Yoshimatsu et al(15) analyzed the results of conservative treatment for CSM in 69 cases and concluded that the disease duration correlated significantly with the clinical outcome. However, Oshima et al(7) indicated that a large range of motion (ROM) and segmental instability at the narrowest canal are considered to be adverse prognostic factors. Among several parameters considered in the present study, the diameter of the CSF column and the existence of segmental instability were identified to be statistically significant. Narrowing of the spinal canal has been demonstrated to be a major risk factor for CSM (23,24). We hypothesized that the presence of cervical spinal stenosis may expose individuals to a greater risk of deterioration of MCSM. Historically, the evaluation of cervical spinal stenosis has been based on the Pavlov ratio in plain lateral radiographs (25). However, the Pavlov ratio may not reflect the impact of soft tissue on MCSM, including hypertrophy of the ligamentum flavum. We consider the diameter of the CSF column on MRI to more accurately reflect the space in the cervical canal. Furthermore, the presence of segmental instability is another risk factor, which indicates that the exacerbation of MCSM is affected not only by static compression, but also by dynamic factors that inflict repeated minor traumas on the spinal cord. Although efforts have been made to identify prognostic factors, it is difficult to predict whether a given factor will be responsible for deterioration in a particular instance. Consequently, it remains to be determined whether patients with MCSM and adverse prognostic factors should be surgically treated as soon as possible to avoid potential deterioration, even if their symptoms and signs are moderate. Furthermore, if non-surgical therapy is adopted, there may be a risk of prolonged conservative treatment resulting in a lost opportunity to obtain satisfactory outcomes after surgery. In an attempt to clarify these points, patients in group A were further followed up postoperatively for ≥1 year. A poor outcome would indicate that patients with adverse prognostic factors require referral to surgery prior to deterioration. By contrast, the absence of a poor outcome would indicate that surgery may be postponed. The results demonstrated that surgical outcomes were relatively good, suggesting it was not too late to perform surgery following the failure of conservative treatments. Thus, although they have a tendency to undergo deterioration, MCSM patients presenting with segmental instability or cervical spinal stenosis may initially be treated conservatively with a close follow-up. Surgical procedures may subsequently be selected when deterioration of myelopathy is clearly identified. However, surgery should be performed in a timely manner since CSM may progress rapidly and a long period of moderate or severe CSM may result in poor prognosis (1–3). In summary, in this study, it was observed that MCSM patients treated conservatively showed a relatively benign clinical course. Segmental instability and cervical spinal stenosis were factors correlating with a poor prognosis. For patients with adverse prognostic factors, conservative treatment remains the recommendation for the first choice action. If conservative treatment fails, timely surgical intervention is likely to be successful. However, this study had several limitations. Firstly, the JOA score system was the only criteria used to select MCSM patients and assess clinical outcomes. The scores were acquired based on the perspective of an investigator and thus were vulnerable to subjectivity. Secondly, patients were followed up for only three years; this relatively short follow-up time weakens the ability of the study to assess the clinical course of MCSM. Consequently, future studies involving reliable, validated assessment tools and long-term follow-up periods are required to further confirm the present findings.
  25 in total

1.  Cervical spondylotic myelopathy: conservative versus surgical treatment after 10 years.

Authors:  Zdeněk Kadaňka; Josef Bednařík; Oldřich Novotný; Igor Urbánek; Ladislav Dušek
Journal:  Eur Spine J       Date:  2011-04-26       Impact factor: 3.134

2.  Good Samaritan cervical traction.

Authors:  J N Borden
Journal:  Clin Orthop Relat Res       Date:  1975 Nov-Dec       Impact factor: 4.176

3.  Prospective cohort study of mild cervical spondylotic myelopathy without surgical treatment.

Authors:  Masatoshi Sumi; Hiroshi Miyamoto; Teppei Suzuki; Shuichi Kaneyama; Takako Kanatani; Koki Uno
Journal:  J Neurosurg Spine       Date:  2011-10-07

4.  Natural course and prognostic factors in patients with mild cervical spondylotic myelopathy with increased signal intensity on T2-weighted magnetic resonance imaging.

Authors:  Yasushi Oshima; Atsushi Seichi; Katsushi Takeshita; Hirotaka Chikuda; Takashi Ono; Satoshi Baba; Jiro Morii; Hiroyuki Oka; Hiroshi Kawaguchi; Kozo Nakamura; Sakae Tanaka
Journal:  Spine (Phila Pa 1976)       Date:  2012-10-15       Impact factor: 3.468

5.  Predictability of operative results of cervical compression myelopathy based on preoperative computed tomographic myelography.

Authors:  T Koyanagi; K Hirabayashi; K Satomi; Y Toyama; Y Fujimura
Journal:  Spine (Phila Pa 1976)       Date:  1993-10-15       Impact factor: 3.468

6.  Surgical treatment of cervical spondylotic myelopathy with anterior compression: a review of 67 cases.

Authors:  Beril Gok; Daniel M Sciubba; Gregory S McLoughlin; Matthew McGirt; Selim Ayhan; Jean-Paul Wolinsky; Ali Bydon; Ziya L Gokaslan; Timothy F Witham
Journal:  J Neurosurg Spine       Date:  2008-08

7.  The prognosis of surgery for cervical compression myelopathy. An analysis of the factors involved.

Authors:  K Fujiwara; K Yonenobu; S Ebara; K Yamashita; K Ono
Journal:  J Bone Joint Surg Br       Date:  1989-05

8.  The developmental segmental sagittal diameter of the cervical spinal canal in patients with cervical spondylosis.

Authors:  W C Edwards; H LaRocca
Journal:  Spine (Phila Pa 1976)       Date:  1983 Jan-Feb       Impact factor: 3.468

9.  Cervical spondylotic myelopathy: surgical results and factors affecting prognosis.

Authors:  S Naderi; S Ozgen; M N Pamir; M M Ozek; C Erzen
Journal:  Neurosurgery       Date:  1998-07       Impact factor: 4.654

10.  Effect of intramedullary signal changes on the surgical outcome of patients with cervical spondylotic myelopathy.

Authors:  Ashish Suri; Ravinder Pal Singh Chabbra; Veer Singh Mehta; Sailesh Gaikwad; Ram Mohan Pandey
Journal:  Spine J       Date:  2003 Jan-Feb       Impact factor: 4.166

View more
  11 in total

1.  Craniocervical instability associated with rheumatoid arthritis: a case report and brief review.

Authors:  Eric Chun-Pu Chu; Arnold Yu-Lok Wong; Linda Yin-King Lee
Journal:  AME Case Rep       Date:  2021-04-25

2.  Decompression for botulinum toxin-exacerbated cervical myeloradiculopathy in the setting of congenital stenosis and Arnold-Chiari I malformation.

Authors:  Abhinav Mohan; Eric Chang
Journal:  Spinal Cord Ser Cases       Date:  2018-05-21

3.  Diagnosis and treatment of hidden lesions in "mild" cervical spondylotic myelopathy patients with apparent symptoms.

Authors:  Yaning Sun; Kunlun Yu; Haonan Wang; Yong Shen; Lingde Kong; Jingtao Zhang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

4.  Predictive factors of symptomatic lumbar canal stenosis in patients after surgery for cervical spondylotic myelopathy.

Authors:  Lingde Kong; Jiangbo Bai; Bing Zhang; Yong Shen; Dehu Tian
Journal:  Ther Clin Risk Manag       Date:  2018-03-07       Impact factor: 2.423

Review 5.  Change in Function, Pain, and Quality of Life Following Structured Nonoperative Treatment in Patients With Degenerative Cervical Myelopathy: A Systematic Review.

Authors:  Lindsay A Tetreault; John Rhee; Heidi Prather; Brian K Kwon; Jefferson R Wilson; Allan R Martin; Ian B Andersson; Anna H Dembek; Krystle T Pagarigan; Joseph R Dettori; Michael G Fehlings
Journal:  Global Spine J       Date:  2017-09-05

Review 6.  Nonoperative Versus Operative Management for the Treatment Degenerative Cervical Myelopathy: An Updated Systematic Review.

Authors:  John Rhee; Lindsay A Tetreault; Jens R Chapman; Jefferson R Wilson; Justin S Smith; Allan R Martin; Joseph R Dettori; Michael G Fehlings
Journal:  Global Spine J       Date:  2017-09-05

7.  Value of Surgery and Nonsurgical Approaches for Cervical Spondylotic Myelopathy: WFNS Spine Committee Recommendations.

Authors:  Jutty Parthiban; Oscar L Alves; Komal Prasad Chandrachari; Premanand Ramani; Mehmet Zileli
Journal:  Neurospine       Date:  2019-09-30

8.  A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.

Authors:  Michael G Fehlings; Lindsay A Tetreault; K Daniel Riew; James W Middleton; Bizhan Aarabi; Paul M Arnold; Darrel S Brodke; Anthony S Burns; Simon Carette; Robert Chen; Kazuhiro Chiba; Joseph R Dettori; Julio C Furlan; James S Harrop; Langston T Holly; Sukhvinder Kalsi-Ryan; Mark Kotter; Brian K Kwon; Allan R Martin; James Milligan; Hiroaki Nakashima; Narihito Nagoshi; John Rhee; Anoushka Singh; Andrea C Skelly; Sumeet Sodhi; Jefferson R Wilson; Albert Yee; Jeffrey C Wang
Journal:  Global Spine J       Date:  2017-09-05

9.  Curative effect of posterior lumbar interbody fusion in the treatment of single-segment lumbar degenerative disease and changes in adjacent segment quantitative score.

Authors:  Yan Zhuang; Feng Zhou; Yunqin Zhang; Zheng Jin
Journal:  Exp Ther Med       Date:  2018-05-11       Impact factor: 2.447

Review 10.  Triaging Spine Surgery and Treatment during the COVID-19 Pandemic.

Authors:  James M Rizkalla; William Hotchkiss; Andrew Clavenna; Andrew Dossett; Ishaq Y Syed
Journal:  J Orthop       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.